Cargando…

Long-Term Follow-Up of Bridging Therapies Prior to CAR T-Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma

SIMPLE SUMMARY: Bridging therapy (BT) in the form of systemic therapy (ST), radiation therapy (RT), or combined-modality therapy (CMT) is increasingly being utilized prior to chimeric antigen receptor (CAR) T-cell therapy for large B-cell lymphoma (LBCL). Prior institutional experiences with BT, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ladbury, Colton, Dandapani, Savita, Hao, Claire, Fabros, Mildred, Amini, Arya, Sampath, Sagus, Glaser, Scott, Sokolov, Karen, Yeh, Jekwon, Baird, John H., Kambhampati, Swetha, Herrera, Alex, Mei, Matthew, Nikolaenko, Liana, Shouse, Geoffrey, Budde, Lihua E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046245/ https://www.ncbi.nlm.nih.gov/pubmed/36980632 http://dx.doi.org/10.3390/cancers15061747

Ejemplares similares

Adjuvant Scrotal Radiation Therapy As Bridging Therapy to Chimeric Antigen Receptor T-Cell Following Extramedullary Relapse in B-Cell Acute Lymphoblastic Leukemia
por: Ladbury, Colton, et al.
Publicado: (2021)

Prognostic Impact of Primary Tumor Extent and Postoperative Radiation Facility Location in Major Salivary Gland Malignancies
por: Ladbury, Colton, et al.
Publicado: (2022)

Combination of yttrium-90 radioembolization with stereotactic body radiation therapy in the treatment of portal vein tumor thrombosis
por: Liu, Jason, et al.
Publicado: (2021)

Oligometastatic Breast Cancer Patients Treated with High-Dose Chemotherapy and Targeted Radiation: Long-Term Follow-Up of a Phase II Trial
por: Ladbury, Colton, et al.
Publicado: (2022)

Stereotactic Radiosurgery in a Small Cell Lung Cancer Patient With Numerous Brain Metastases
por: Lian, Andrew, et al.
Publicado: (2022)

Long-term follow up of patients with hematological malignancies treated with total body irradiation using intensity modulated radiation therapy
por: Ladbury, Colton, et al.
Publicado: (2022)

Clinical Applications of Magnetic Resonance-Guided Radiotherapy: A Narrative Review
por: Ladbury, Colton, et al.
Publicado: (2023)

Utilization of model-agnostic explainable artificial intelligence frameworks in oncology: a narrative review
por: Ladbury, Colton, et al.
Publicado: (2022)

Assessment of Barriers and Challenges to Screening, Diagnosis, and Biomarker Testing in Early-Stage Lung Cancer
por: Zarinshenas, Reza, et al.
Publicado: (2023)

Infectious complications in patients with relapsed refractory multiple myeloma after BCMA CAR T-cell therapy
por: Kambhampati, Swetha, et al.
Publicado: (2022)

Early Stage and Locally Advanced Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Going?
por: Juarez-Vignon Whaley, Juan Jose, et al.
Publicado: (2023)

Prolonged response to checkpoint inhibitor therapy in two metastatic mucoepidermoid salivary gland carcinoma cases: a research report
por: Pharaon, Rebecca R., et al.
Publicado: (2022)

Interferon-γ blockade in CAR T-cell therapy–associated macrophage activation syndrome/hemophagocytic lymphohistiocytosis
por: Rainone, Michael, et al.
Publicado: (2022)

Volumetric modulated arc therapy based total marrow and lymphoid irradiation: Workflow and clinical experience
por: Ladbury, Colton, et al.
Publicado: (2023)

An Analysis and Comparison of Survival and Functional Outcomes in Oropharyngeal Squamous Cell Carcinoma Patients Treated with Concurrent Chemoradiation Therapy within City of Hope Cancer Center Sites
por: Pharaon, Rebecca, et al.
Publicado: (2020)

Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading?
por: Juarez-Vignon Whaley, Juan Jose, et al.
Publicado: (2023)

Integration of artificial intelligence in lung cancer: Rise of the machine
por: Ladbury, Colton, et al.
Publicado: (2023)

Shifting paradigms: whole brain radiation therapy versus stereotactic radiosurgery for brain metastases
por: Shinde, Ashwin, et al.
Publicado: (2019)

Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy
por: Kilgour, Marisa K., et al.
Publicado: (2023)

Combination radiation and immunotherapy in gynecologic malignancies—a comprehensive review
por: Ladbury, Colton, et al.
Publicado: (2021)

Current landscape of radiation oncology in esophageal cancer: a narrative review
por: Liu, Jason, et al.
Publicado: (2022)

Seatbelts in CAR therapy: How Safe Are CARS?
por: Minagawa, Kentaro, et al.
Publicado: (2015)

CAR-T Cell Therapy
por: Ahmad, Aamir
Publicado: (2020)

CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
por: Pan, Kevin, et al.
Publicado: (2022)

The development of CAR design for tumor CAR-T cell therapy
por: Xu, Dandan, et al.
Publicado: (2018)

Engineering switchable and programmable universal CARs for CAR T therapy
por: Liu, Delong, et al.
Publicado: (2019)

Ablative Radiotherapy as a Strategy to Overcome TKI Resistance in EGFR-Mutated NSCLC
por: Novak, Jennifer, et al.
Publicado: (2022)

Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Kulemzin, Sergey, et al.
Publicado: (2021)

Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma
por: Kennedy, Vanessa E., et al.
Publicado: (2021)

Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients
por: Sampath, Sagus, et al.
Publicado: (2018)

Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma
por: Sidana, Surbhi, et al.
Publicado: (2023)

CAR T Cell Therapy for Neuroblastoma
por: Richards, Rebecca M., et al.
Publicado: (2018)

Target selection for CAR-T therapy
por: Wei, Jianshu, et al.
Publicado: (2019)

Gut microbiome and CAR-T therapy
por: Abid, Muhammad Bilal, et al.
Publicado: (2019)

The Application of Nanobody in CAR-T Therapy
por: Bao, Chaolemeng, et al.
Publicado: (2021)

CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy
por: Harrer, Dennis Christoph, et al.
Publicado: (2023)

Role of radiotherapy in treatment of extramedullary relapse following total marrow and lymphoid irradiation in high-risk and/or relapsed/refractory acute leukemia
por: Ladbury, Colton, et al.
Publicado: (2022)

CD19-directed CAR T-cell therapy for treatment of primary CNS lymphoma
por: Siddiqi, Tanya, et al.
Publicado: (2021)

CAR-T Cell Therapy: From the Shop to Cancer Therapy
por: Uscanga-Palomeque, Ashanti Concepción, et al.
Publicado: (2023)

Difficulties in Defining Oligometastatic Prostate Cancer: Implications for Clinical Trial Accrual and Community Practice Adoption of Metastasis-Directed Therapy Approaches
por: Dorff, Tanya Barauskas, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jscu25ndl8cq0ph46s5cs4ik0m